Actinium Pharmaceuticals Langfristige Verbindlichkeiten 2011-2026 | ATNM

Langfristige Verbindlichkeiten Jährlich Actinium Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000
-	-	-	-	-	-	682 K	13.4 K	-	-	-	-	-	-	58.2 K	-	-	-	-	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
682 K	13.4 K	251 K

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	355 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 34.45	4.74 %	$ 927 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Forte Biosciences FBRX	10.5 M	$ 20.31	1.2 %	$ 263 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Grifols, S.A. GRFS	10.6 B	$ 8.19	4.46 %	$ 5.57 B	Spain
Celyad Oncology SA CYAD	4.97 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 6.82	1.94 %	$ 187 M	Israel
Generation Bio Co. GBIO	132 M	-	-	$ 344 M	USA
IMV IMV	8.95 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	622 M	$ 90.36	2.93 %	$ 21.8 B	Germany
Autolus Therapeutics plc AUTL	50.6 M	$ 1.62	-0.61 %	$ 431 M	Britain
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	31.3 M	$ 2.71	-0.92 %	$ 253 M	Israel
Anika Therapeutics ANIK	26.1 M	$ 15.14	2.16 %	$ 217 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	315 M	$ 97.08	1.55 %	$ 19 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.39	4.17 %	$ 5.58 M	Israel
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	189 M	$ 1.51	2.03 %	$ 177 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 20.47	4.97 %	$ 2.6 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA